Fresenius Medical Care AG (NYSE:FMS) Given Average Rating of “Hold” by Brokerages

Shares of Fresenius Medical Care AG (NYSE:FMS) have received a consensus recommendation of “Hold” from the five analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $24.30.

FMS has been the topic of a number of recent analyst reports. Berenberg Bank initiated coverage on shares of Fresenius Medical Care in a report on Wednesday, November 6th. They set a “buy” rating and a $25.60 target price on the stock. StockNews.com initiated coverage on shares of Fresenius Medical Care in a report on Saturday. They set a “strong-buy” rating on the stock. Finally, Truist Financial boosted their target price on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a report on Monday, October 7th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of FMS. Allworth Financial LP boosted its holdings in shares of Fresenius Medical Care by 53.1% during the third quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after acquiring an additional 581 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Fresenius Medical Care by 50.4% during the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock worth $106,000 after acquiring an additional 1,675 shares during the period. ORG Wealth Partners LLC bought a new stake in shares of Fresenius Medical Care during the third quarter worth approximately $112,000. Venturi Wealth Management LLC boosted its holdings in shares of Fresenius Medical Care by 1,045.8% during the third quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock worth $112,000 after acquiring an additional 4,800 shares during the period. Finally, ORG Partners LLC bought a new stake in shares of Fresenius Medical Care during the first quarter worth approximately $110,000. 8.25% of the stock is owned by institutional investors.

Fresenius Medical Care Stock Performance

Shares of FMS stock opened at $21.22 on Wednesday. The company’s fifty day simple moving average is $20.50 and its 200-day simple moving average is $20.22. The company has a quick ratio of 1.09, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a market cap of $12.45 billion, a PE ratio of 17.68, a P/E/G ratio of 0.98 and a beta of 0.91. Fresenius Medical Care has a 12 month low of $17.49 and a 12 month high of $22.76.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.